Novonesis AS (Novonesis AS) 3-Year Revenue Growth Rate : 9.00% (As of Dec. 2023)

View and export this data going back to 2009. Start your Free Trial

What is Novonesis AS 3-Year Revenue Growth Rate?

Novonesis AS's Revenue per Share for the three months ended in Dec. 2023 was $2.42.

During the past 12 months, Novonesis AS's average Revenue per Share Growth Rate was 2.30% per year. During the past 3 years, the average Revenue per Share Growth Rate was 9.00% per year. During the past 5 years, the average Revenue per Share Growth Rate was 6.20% per year. During the past 10 years, the average Revenue per Share Growth Rate was 4.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 13 years, the highest 3-Year average Revenue per Share Growth Rate of Novonesis AS was 11.40% per year. The lowest was 0.50% per year. And the median was 8.00% per year.

Competitive Comparison of Novonesis AS's 3-Year Revenue Growth Rate

For the Specialty Chemicals subindustry, Novonesis AS's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Novonesis AS's 3-Year Revenue Growth Rate Distribution in the Chemicals Industry

For the Chemicals industry and Basic Materials sector, Novonesis AS's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where Novonesis AS's 3-Year Revenue Growth Rate falls into.

Novonesis AS 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

Novonesis AS (OTCPK:NVZMY) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.

Novonesis AS 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of Novonesis AS's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Novonesis AS (Novonesis AS) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Novonesis AS (OTCPK:NVZMY) » Definitions » 3-Year Revenue Growth Rate

Comparable Companies

Traded in Other Exchanges

NVZMF:USA NZYM:Mexico NZYMBc:UK 0Q4U:UK NZYM B:Denmark NZM2:Germany

Address

Krogshoejvej 36, Bagsvaerd, DNK, 2880

Website

https://www.novozymes.com

Novozymes is the world leader in industrial enzymes. In recent years, the company has expanded into micro-organisms, primarily for agricultural markets. The firm supplies five major industry groups: household care, food and beverages, bioenergy, agriculture and feed, and technical and pharma. Its biological solutions create value for its customers by improving yield efficiency and performance, while saving energy and generating less waste. The company is headquartered in Denmark.

Novonesis AS (Novonesis AS) Headlines

From GuruFocus

Novozymes Named EPA Safer Choice Partner of the Year for Third Year in a Row

By PRNewswire • 10-03-2023

Not Just Yogurt Anymore

By PRNewswire • 10-26-2023

2 Holdings to Reduce Based on Analyst Recommendations

By Alberto Abaterusso Alberto Abaterusso • 11-06-2019

Novozymes A/S's Dividend Analysis

By GuruFocus Research • 10-19-2023